Vijay Kedia’s Multibagger Stock Jumps 1200 per cent; Huge Revenue Realization to be Seen by FY24!
Vijay Kedia’s Multibagger Stock Jumps 1200 per cent; Huge Revenue Realization to be Seen by FY24!

Vijay Kedia’s Multibagger Stock Jumps 1200 per cent; Huge Revenue Realization to be Seen by FY24!

The company has to execute 13,458 orders in the next five months, until March 2024, where massive revenue awaits entry into the company's income statement.

Prajwal Wakhare Article rating: 3.5

The company's order book has shown a significant increase, from 10,240 orders in October 2022 to 18,001 orders in October 2023, a growth rate of 75.79 per cent. Automation orders grew by 44.33 per cent, while Car Parking orders saw a substantial 135.5 per cent growth.

From Rs 40 to Rs 500: This multibagger Smallcap pharma stock recorded over 1000 per cent returns in just 3 years! Know its story here
From Rs 40 to Rs 500: This multibagger Smallcap pharma stock recorded over 1000 per cent returns in just 3 years! Know its story here

From Rs 40 to Rs 500: This multibagger Smallcap pharma stock recorded over 1000 per cent returns in just 3 years! Know its story here

The capsule manufacturing capacity is around 18 BCPA (Billion capsules per annum), which is likely to see a significant rise to 22 BCPA via capital expansion in this fiscal year.

Rohit Kale Article rating: 4.2

This smallcap company, belonging to the pharma domain, has exhibited strong growth phase along with improvement in financial numbers.

Here’s a list of the top 10 gainers for March! Do you own any?
Here’s a list of the top 10 gainers for March! Do you own any?

Here’s a list of the top 10 gainers for March! Do you own any?

Despite the current weakness in the market, such stocks have witnessed strong buying interest in the month of March.

Rohit Kale Article rating: 4.9

The end to the financial year 2022-23 was quite painful as Nifty lost over 1,500 points in just over 3 months. The domestic market is the one of the most underperforming markets in the world in recent times, which has taken a toll on investors’ sentiment.

From Rs 33 to Rs 394: This low PE Smallcap stock became multibagger in just 3 years!
From Rs 33 to Rs 394: This low PE Smallcap stock became multibagger in just 3 years!

From Rs 33 to Rs 394: This low PE Smallcap stock became multibagger in just 3 years!

The company reported a jump of 85 per cent in net profit to Rs 53.09 crore for Q3FY23 with improvement in margins.

Rohit Kale Article rating: 4.1

The stock has been a proven multibagger, having soared over 10 times since March 2020 low of Rs 33 to Rs 394 level in March 2023.

RSS
1234

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList